FRESENIUS MEDICAL CARE AG Foreign Exchange Gain
FRESENIUS MEDICAL CARE AG (FMCQF) reported Foreign Exchange Gain of EUR 359.96 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Income Statement › Other Income
ifrs-full:ForeignExchangeGain · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG foreign exchange gain for the quarter ending 2025-12-31 was 58.55M EUR, a 65.77% decline year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange gain for the quarter ending 2025-09-30 was 36.20M EUR, a 40.92% decline year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange gain for the quarter ending 2025-06-30 was 293.39M EUR, a 405.56% increase year-over-year.
- FRESENIUS MEDICAL CARE AG foreign exchange gain for the quarter ending 2025-03-31 was 114.92M EUR, a 86.32% increase year-over-year.
| Period end | Foreign Exchange Gain 3 month | Foreign Exchange Gain 6 month | Foreign Exchange Gain 9 month | Foreign Exchange Gain 12 month |
|---|---|---|---|---|
| 2025-12-31 | 58.55M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 94.75M EUR derived: sum of 2 quarters · filed 2026-02-24 | 388.15M EUR derived: sum of 3 quarters · filed 2026-02-24 | 359.96M EUR 20-F · filed 2026-02-24 |
| 2025-09-30 | 36.20M EUR 6-K · filed 2025-11-04 | 329.60M EUR derived: sum of 2 quarters · filed 2025-11-04 | 301.41M EUR 6-K · filed 2025-11-04 | 615.57M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | 293.39M EUR 6-K · filed 2025-08-05 | 408.31M EUR 6-K · filed 2025-08-05 | 579.37M EUR derived: sum of 3 quarters · filed 2026-02-24 | 640.64M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | 114.92M EUR 6-K · filed 2025-05-06 | 285.97M EUR derived: sum of 2 quarters · filed 2026-02-24 | 347.25M EUR derived: sum of 3 quarters · filed 2026-02-24 | 405.28M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | 171.06M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 232.33M EUR derived: sum of 2 quarters · filed 2026-02-24 | 290.37M EUR derived: sum of 3 quarters · filed 2026-02-24 | 352.04M EUR 20-F · filed 2026-02-24 |
| 2024-09-30 | 61.27M EUR 6-K · filed 2025-11-04 | 119.31M EUR derived: sum of 2 quarters · filed 2025-11-04 | 180.98M EUR 6-K · filed 2025-11-04 | 292.57M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 58.03M EUR 6-K · filed 2025-08-05 | 119.71M EUR 6-K · filed 2025-08-05 | 231.30M EUR derived: sum of 3 quarters · filed 2026-02-24 | 274.05M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 61.68M EUR 6-K · filed 2025-05-06 | 173.26M EUR derived: sum of 2 quarters · filed 2026-02-24 | 216.02M EUR derived: sum of 3 quarters · filed 2026-02-24 | 269.86M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 111.59M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 154.34M EUR derived: sum of 2 quarters · filed 2026-02-24 | 208.18M EUR derived: sum of 3 quarters · filed 2026-02-24 | 280.32M EUR 20-F · filed 2026-02-24 |
| 2023-09-30 | 42.76M EUR 6-K · filed 2024-11-05 | 96.60M EUR derived: sum of 2 quarters · filed 2024-11-05 | 168.74M EUR 6-K · filed 2024-11-05 | 207.67M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 53.84M EUR 6-K · filed 2024-07-30 | 125.98M EUR 6-K · filed 2024-07-30 | 164.91M EUR derived: sum of 3 quarters · filed 2025-02-25 | 237.45M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 72.14M EUR 6-K · filed 2024-05-07 | 111.07M EUR derived: sum of 2 quarters · filed 2025-02-25 | 183.61M EUR derived: sum of 3 quarters · filed 2025-02-25 | 273.14M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 38.93M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 111.47M EUR derived: sum of 2 quarters · filed 2025-02-25 | 201.00M EUR derived: sum of 3 quarters · filed 2025-02-25 | 306.62M EUR 20-F · filed 2025-02-25 |
| 2022-09-30 | 72.54M EUR 6-K · filed 2023-11-02 | 162.07M EUR derived: sum of 2 quarters · filed 2023-11-02 | 267.69M EUR 6-K · filed 2023-11-02 | |
| 2022-06-30 | 89.53M EUR 6-K · filed 2023-08-02 | 195.15M EUR 6-K · filed 2023-08-02 | ||
| 2022-03-31 | 105.62M EUR 6-K · filed 2023-05-09 | |||
| 2021-12-31 | 381.30M EUR 20-F · filed 2024-02-20 |